TabletsClinical Overview
Ketorolac Tromethamine Tablets / Dispersible Tablets (10mg) is an oral pyrrolizine carboxylic acid NSAID on the WHO Model List framework for short-term continuation therapy following IV ketorolac. It exerts potent analgesic and moderate anti-inflammatory action via cyclooxygenase inhibition. Indicated ONLY as continuation therapy to parenteral ketorolac for moderate-to-severe acute postoperative pain, for a total combined duration not exceeding 5 days.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 10 mg every 4 to 6 hours as needed with a full glass of water, with or after meals. Dispersible tablets: Disperse in a tablespoon of water and swallow immediately. Maximum oral daily dose is 40 mg. Maximum combined duration (IV + oral) must NOT exceed 5 days.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, dyspepsia, abdominal pain, headache, dizziness, edema. Rare/Severe: Severe gastrointestinal perforation/bleeding, acute renal failure, and hypersensitivity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black Box Warning: STRICT 5-DAY MAXIMUM TREATMENT LIMIT across all routes; prolonged use dramatically escalates fatal GI bleeding and acute renal failure. Not indicated for chronic painful conditions (arthritis). Contraindicated in active peptic ulcers, bleeding diathesis, and renal impairment.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.
Ketorolac Tromethamine Tablets 10mg
Ketorolac Tromethamine Tablets / Dispersible Tablets (10mg) is an oral pyrrolizine carboxylic acid NSAID on the WHO Model List framework for short-term continuation therapy following IV ketorolac. It exerts potent analgesic and moderate anti-inflammatory action via cyclooxygenase inhibition. Indicated ONLY as continuation therapy to parenteral ketorolac for moderate-to-severe acute postoperative pain, for a total combined duration not exceeding 5 days.
Ketorolac Injection 30mg per ml
Ketorolac Tromethamine Injection (30mg/ml) is a parenteral pyrrolo-pyrrole NSAID on the WHO Model List of Essential Medicines. It provides powerful non-opioid analgesia comparable to therapeutic doses of morphine by potently inhibiting COX-1 and COX-2 without causing respiratory depression, sedation, or bowel hypomotility. Indicated for short-term management (up to 5 days only) of moderate-to-severe acute postoperative surgical pain.
Ketorolac Tromethamine Ophthalmic Solution 0.4% w/v
Ketorolac Tromethamine Ophthalmic Solution (0.4% w/v) is a topical ocular NSAID on the WHO Model List framework. It inhibits ocular cyclooxygenase to block ocular prostaglandin synthesis, preventing intraoperative miosis and relieving postoperative ocular inflammation and photophobia following cataract surgery and refractive surgery.
Ketorolac (0.5% W/V) + Moxifloxacin (0.5% W/V) Eye Drops
Moxifloxacin and NSAID (Bromfenac 0.09% or Ketorolac 0.5%) ophthalmic solution is an antibacterial and non-steroidal anti-inflammatory combination. Moxifloxacin provides broad bactericidal coverage, while the ophthalmic NSAID inhibits cyclooxygenase (COX-1/COX-2) enzymes to block prostaglandin synthesis, relieving ocular pain, photophobia, and anterior chamber flare without the intraocular pressure spikes or cataract risks associated with steroids. Indicated for post-cataract surgery ocular pain, inflammation, and infection prophylaxis.